IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction
- 30 September 2013
- journal article
- research article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 132 (4), 933-941
- https://doi.org/10.1016/j.jaci.2013.05.012
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- IL-33 is a crucial amplifier of innate rather than acquired immunityProceedings of the National Academy of Sciences of the United States of America, 2010
- A Large-Scale, Consortium-Based Genomewide Association Study of AsthmaNew England Journal of Medicine, 2010
- IL-33 Amplifies the Polarization of Alternatively Activated Macrophages That Contribute to Airway InflammationThe Journal of Immunology, 2009
- Blocking IL-25 prevents airway hyperresponsiveness in allergic asthmaJournal of Allergy and Clinical Immunology, 2007
- IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated CytokinesImmunity, 2005
- Expression and function of the ST2 gene in a murine model of allergic airway inflammationClinical and Experimental Allergy, 2002
- Critical Role for IL-13 in the Development of Allergen-Induced Airway HyperreactivityPublished by The American Association of Immunologists ,2001
- Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammationJCI Insight, 2000
- Crucial Role of the Interleukin 1 Receptor Family Member T1/St2 in T Helper Cell Type 2–Mediated Lung Mucosal Immune ResponsesThe Journal of Experimental Medicine, 1999
- Requirement for IL-13 Independently of IL-4 in Experimental AsthmaScience, 1998